SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001607062-21-000257
Filing Date
2021-08-05
Accepted
2021-08-05 12:17:25
Documents
51
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q rgbp063020form10q.htm 10-Q 1509870
2 EXHIBIT 31.1 ex31_1.htm EX-31.1 9501
3 EXHIBIT 31.2 ex31_2.htm EX-31.2 9480
4 EXHIBIT 32.1 ex32_1.htm EX-32.1 4226
5 EXHIBIT 32.2 ex32_2.htm EX-32.2 4097
  Complete submission text file 0001607062-21-000257.txt   4971600

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE rgbp-20200630.xml EX-101.INS 763166
7 XBRL SCHEMA FILE rgbp-20200630.xsd EX-101.SCH 73426
8 XBRL CALCULATION FILE rgbp-20200630_cal.xml EX-101.CAL 53348
9 XBRL DEFINITION FILE rgbp-20200630_def.xml EX-101.DEF 194763
10 XBRL LABEL FILE rgbp-20200630_lab.xml EX-101.LAB 352218
11 XBRL PRESENTATION FILE rgbp-20200630_pre.xml EX-101.PRE 259782
Mailing Address 4700 SPRING ST #304 LA MESA CA 91942
Business Address 4700 SPRING ST #304 LA MESA CA 91942 619-722-5505
Regen BioPharma Inc (Filer) CIK: 0001589150 (see all company filings)

IRS No.: 455192997 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 333-191725 | Film No.: 211147157
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences